DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR LINEZOLID

« Back to Dashboard

Clinical Trials for Linezolid

Trial ID	Title	Status	Sponsor	Phase	Summary
NCT00035269	New Antibiotic to Treat Patients With Community-acquired Pneumonia Due to a Specific Bacteria (S. Pneumoniae Pneumonia)	Completed	Pfizer	Phase 3	This study will treat patients who have a community-acquired pneumonia that is due to a specific bacteria (S. pneumoniae)
NCT00035425	Treatment of Neutropenic Patients With Fever Who Are Suspected to Have A Gram Positive Infection	Completed	Pfizer	Phase 3	This study will treat patients who have fever and neutropenia (after cancer chemotherapy) that is possibly due to a specific bacteria (gram positive bacteria).
NCT00035854	New Antibiotic to Treat Pediatric Patients With Infections Due to a Specific Bacteria (Vancomycin-Resistant Enterococcus)	Completed	Pfizer	Phase 3	This study will treat pediatric patients who have infections that are due to a specific bacteria (Vancomycin-Resistant Enterococcus)
NCT00037050	Antibiotic Treatment for Infections of Short Term In-dwelling Vascular Catheters Due to Gram Positive Bacteria	Completed	Pfizer	Phase 3	This study will treat patients who have a short term central catheter that is thought to be infected with a specific bacteria (gram positive bacteria)
NCT00084266	Nosocomial Pneumonia With Suspected Or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA)	Completed	Pfizer	Phase 4	To determine if linezolid is superior to vancomycin in the treatment of nosocomial (acquired in the hospital) pneumonia due to Methicillin Resistant Staphylococcus Aureus (MRSA) in adult subjects. Subjects entered in to the study will have proven healthcare-associated methicillin-resistant Staphylococcus aureus pneumonia which will be treated with either linezolid or vancomycin.

Clinical Trial Conditions for Linezolid

Condition Name

Condition Name for Linezolid
Intervention	Trials
Bacterial Infections	9
Gram-Positive Bacterial Infections	8
Pneumonia	6
Tuberculosis	5

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Linezolid
Intervention	Trials
Infection	40
Communicable Diseases	35
Tuberculosis	24
Bacterial Infections	22

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Linezolid

Trials by Country

Trials by Country for Linezolid
Location	Trials
United States	365
China	45
South Africa	39
Brazil	15
Spain	15

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Linezolid
Location	Trials
California	27
Georgia	22
Texas	22
Ohio	20
Florida	19

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Linezolid

Clinical Trial Phase

Clinical Trial Phase for Linezolid
Clinical Trial Phase	Trials
Phase 4	16
Phase 3	35
Phase 2/Phase 3	3

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Linezolid
Clinical Trial Phase	Trials
Completed	52
Recruiting	19
Not yet recruiting	16

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Linezolid

Sponsor Name

Sponsor Name for Linezolid
Sponsor	Trials
Pfizer	29
Paratek Pharmaceuticals Inc	5
Global Alliance for TB Drug Development	4

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Linezolid
Sponsor	Trials
Other	113
Industry	73
U.S. Fed	3

Export unavailable in trial.
Subscribe for complete access.